Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Transfus Med ; 26(5): 365-372, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27350440

RESUMEN

BACKGROUND AND OBJECTIVES: The effect of leukoreduction and storage periods on the accumulation of bioactive lysophospholipids and substances in human autologous blood (AB units) has not been fully investigated. MATERIALS AND METHODS: The accumulation of bioactive lysophospholipids such as sphingosine 1-phosphate (S1P) and lysophosphatidylserine (LysoPS) in AB units during the storage was investigated. The time-dependent changes and the effect of the filtration in pre-storage leuckoreduction (LR) and unmodified samples derived from 46 AB units were analysed. Additionally, the changes of lysophospholipids and platelet releasate, namely ß-thromboglobulin (ß-TG), induced by exposure of whole blood (WB) or platelet-rich plasma (PRP) to the filter material were analysed. RESULTS: LysoPS, but not S1P levels, time-dependently and significantly increased in both unmodified and LR samples. LysoPS significantly decreased in LR compared with unmodified samples, whereas S1P increased in LR compared with unmodified samples. In addition, exposure of WB and/or PRP to the filter material in vitro resulted in increased levels of S1P, LysoPS and ß-TG. CONCLUSIONS: LR effectively reduced the accumulation of LysoPS in AB units. On the other hand, it increased concentrations of S1P due to platelet activation by exposure to the filter material. These suggest that increases of S1P levels in LR and LysoPS in the unmodified samples were mainly caused by the leukocytes and/or platelets and that LR was effective in inhibiting the accumulation of LysoPS.


Asunto(s)
Conservación de la Sangre , Transfusión de Sangre Autóloga , Procedimientos de Reducción del Leucocitos , Lisofosfolípidos/sangre , Esfingosina/análogos & derivados , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Esfingosina/sangre
2.
J Dent Res ; 89(11): 1309-14, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20739703

RESUMEN

We have reported that mustard oil application to the rat dental pulp induces neuronal activation in the thalamus. To address the mechanisms involved in the thalamic changes, we performed neuronal responsiveness recording, immunohistochemistry, and molecular biological analysis. After mustard oil application, neuronal responsiveness was increased in the mediodorsal nucleus. When MK801 (an N-methyl-D-aspartate receptor antagonist) was applied to the mediodorsal nucleus, the enhanced responsiveness was decreased. N-methyl-D-aspartate receptor 2D, glial fibrillary acidic protein, and antigen-presenting cell-related gene mRNAs in the contralateral thalamus were up-regulated at 10 minutes after mustard oil application, but were down-regulated within 10 minutes after the antagonist application. OX6-expressing microglia and glial fibrillary acidic protein-expressing astrocytes did not increase until 60 minutes after mustard oil application. These results suggested that the thalamic neurons play some roles in regulating the glial cell activation in the mediodorsal nucleus via N-methyl-D-aspartate receptor 2D during pulp inflammation-induced central sensitization.


Asunto(s)
Pulpa Dental/efectos de los fármacos , Planta de la Mostaza/efectos adversos , Aceites de Plantas/efectos adversos , Tálamo/inmunología , Animales , Células Presentadoras de Antígenos/inmunología , Astrocitos/inmunología , Astrocitos/fisiología , Pulpa Dental/inmunología , Pulpa Dental/inervación , Maleato de Dizocilpina/farmacología , Estimulación Eléctrica , Antagonistas de Aminoácidos Excitadores/farmacología , Proteína Ácida Fibrilar de la Glía/análisis , Inmunohistoquímica , Masculino , Núcleo Talámico Mediodorsal/efectos de los fármacos , Núcleo Talámico Mediodorsal/fisiología , Microglía/inmunología , Microglía/fisiología , Diente Molar/efectos de los fármacos , Diente Molar/inmunología , Diente Molar/inervación , Biología Molecular , Vías Nerviosas/inmunología , Neuroglía/inmunología , Neuroglía/fisiología , Neuroinmunomodulación/inmunología , Neuroinmunomodulación/fisiología , Neuronas/inmunología , Neuronas/fisiología , Pulpitis/inducido químicamente , Pulpitis/inmunología , Ratas , Ratas Sprague-Dawley , Receptores de N-Metil-D-Aspartato/análisis , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Tálamo/efectos de los fármacos
3.
Equine Vet J Suppl ; (36): 654-8, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17402500

RESUMEN

REASONS FOR PERFORMING STUDY: In laboratory animals, man and cell culture experiments, milk basic protein was reported to suppress bone resorption and promote bone formation. However, no studies in horses have previously examined the effect of milk basic protein. OBJECTIVES: To evaluate the effect of milk basic protein supplementation on bone metabolism in young Thoroughbred horses in training. METHODS: Twenty 2-year-old horses in training were used for 90 days in this study. The treatment group was fed a basal diet with 1 g of milk basic protein and the control group a basal diet only. Blood samples were collected on Days 0, 45 and 90 to determine serum calcium (Ca) and biochemical markers of bone metabolism. Radiographs were taken at the start and end of the study to determine radiographic bone aluminium equivalence (RBAE). RESULTS: Serum osteocalcin (OC) was significantly higher at Day 45 after the beginning of the study in the treatment group compared to that in the control group. The treatment group showed a greater increase in the total RBAE change at the end of this study compared to that in the control group. However, there were no significant differences in serum Ca and carboxy-terminal telopeptide of type I collagen (ICTP) between groups. CONCLUSIONS AND POTENTIAL RELEVANCE: These findings provide preliminary evidence that milk basic protein has an effect on bone formation in 2-year-old Thoroughbred horses in training. However, further studies in larger groups of horses are now required to substantiate our findings.


Asunto(s)
Huesos/efectos de los fármacos , Huesos/metabolismo , Calcio/sangre , Proteínas en la Dieta/administración & dosificación , Caballos/metabolismo , Condicionamiento Físico Animal/fisiología , Animales , Densidad Ósea/efectos de los fármacos , Densidad Ósea/fisiología , Huesos/diagnóstico por imagen , Femenino , Masculino , Proteínas de la Leche/administración & dosificación , Osteocalcina/sangre , Osteogénesis/efectos de los fármacos , Osteogénesis/fisiología , Radiografía , Factores de Tiempo
4.
Phytother Res ; 16(1): 43-7, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11807964

RESUMEN

Studies previously conducted in our laboratory have shown that an extract from the leaves of Chromo-laena odorata is mitogenic for human skin fibroblasts and keratinocytes. However, lipopolysaccharides, sometimes present in plant extracts, can also play a role in cell growth and might have been responsible for or contributed to the mitogenic activity observed. The present study aimed to investigate whether a lipopolysaccharide would have any effect on the proliferation of human fibroblasts and keratinocytes. Cells were seeded in 96-well plates and concentrations from 0.0 to 5.0 microg/mL of lipopolysaccharide in basal or growth medium were added. Cell growth was determined over a period of 10 days using a colorimetric assay. Lipopolysaccharide at concentrations between 0.05 microg/mL and 0.5 microg/mL in the growth medium significantly stimulated fibroblast proliferation after incubation for more than 6 days. In basal medium, more than 8 days of incubation was needed for significant stimulation of growth. Lipopolysaccharide stimulation of keratinocytes was evident at 0.5 microg/mL by day 3 in basal medium and by day 5 in growth medium. Although the lipopolysaccharide did stimulate cell growth it did so only at higher concentrations than were present in our plant extracts and to a lesser degree.


Asunto(s)
Fibroblastos/efectos de los fármacos , Queratinocitos/efectos de los fármacos , Lipopolisacáridos/farmacología , División Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Fibroblastos/citología , Humanos , Queratinocitos/citología , Masculino , Factores de Tiempo
5.
Jpn J Pharmacol ; 86(1): 32-7, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11430470

RESUMEN

To clarify the contractile mechanism of Dai-kenchu-to, the effects of hydroxy beta-sanshool (an ingredient of Zanthoxylum fruit), Zanthoxylum fruit (a constituent herb of Dai-kenchu-to) and Dai-kenchu-to were studied in mucosa-free longitudinal muscle of guinea pig ileum. Hydroxy beta-sanshool at 10(-7)-10(-5) g/ml induced dose-related contractions accompanied by autonomous contraction and produced an initial contraction at a concentration of 10(-4) g/ml or more. The contraction induced by hydroxy beta-sanshool (10(-5) g/ml) was significantly inhibited by tetrodotoxin or the capsaicin-receptor antagonist capsazepine. Although atropine or the substance P antagonist spantide tended to inhibit the contraction, a combination of atropine and spantide almost abolished the contraction by hydroxy beta-sanshool. The P2-purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid did not affect hydroxy beta-sanshool-induced contraction in the presence or absence of spantide. The tonic contractions by Zanthoxylum fruit (2 x 10(-4) g/ml) and Dai-kenchu-to (10(-3) g/ml) were significantly inhibited or tended to be inhibited by atropine, spantide, tetrodotoxin or capsazepine and were remarkably suppressed by the combination of atropine and spantide. These results suggested that acetylcholine release from intrinsic cholinergic nerves and tachykinins from sensory neurons are involved in the contractions induced by hydroxy beta-sanshool and that tachykinins may be involved in the atropine-resistant contraction by Dai-kenchu-to.


Asunto(s)
Atropina/antagonistas & inhibidores , Antagonistas Muscarínicos/farmacología , Músculo Liso/efectos de los fármacos , Extractos Vegetales/farmacología , Sustancia P/análogos & derivados , Animales , Atropina/farmacología , Relación Dosis-Respuesta a Droga , Cobayas , Íleon/efectos de los fármacos , Técnicas In Vitro , Masculino , Contracción Muscular/efectos de los fármacos , Panax , Preparaciones Farmacéuticas , Sustancia P/antagonistas & inhibidores , Sustancia P/farmacología , Zanthoxylum , Zingiberaceae
6.
Int Immunopharmacol ; 1(2): 219-27, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11360923

RESUMEN

The susceptibility to oral tolerance in post-neonatal infant mice and the effect of a herbal drug, Hochu-ekki-to (HOT), on the susceptibility were investigated. To induce oral tolerance induction, infant and adult mice at 4 and 8 weeks of age, respectively, were orally administered a single high dose of OVA before an intraperitoneal immunization with OVA adsorbed on aluminum hydroxide. HOT (1000 mg/kg) was administered orally for 7 days before the induction. HOT significantly decreased the serum levels of OVA-specific IgE and IgG1 and the antigen-specific proliferation of spleen cells in infant mice, both of which were greatly enhanced compared to in adult mice. HOT increased the number of both CD4+ T cells and antigen-presenting cells expressing MHC class II as well as costimulatory molecules (CD40, CD80 and/or CD86) in the Peyer's patch (PP) of infant mice, which had fewer cells than adult mice. In the PP, moreover, HOT augmented the IL-12p40 mRNA expression and spontaneous or CD40-stimulated IL-12 production, and increased the number of CD4+ cells expressing CD40 ligand, which is up regulated by IL-12. These results suggest that HOT increases the number and improves the function of PP cells that are fully susceptible to the induction of oral tolerance.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Medicamentos Herbarios Chinos/farmacología , Tolerancia Inmunológica/efectos de los fármacos , Administración Oral , Animales , Animales Recién Nacidos , Femenino , Interleucina-12/biosíntesis , Activación de Linfocitos/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Ovalbúmina/inmunología , Ganglios Linfáticos Agregados/efectos de los fármacos , Ganglios Linfáticos Agregados/fisiología , Subgrupos de Linfocitos T/efectos de los fármacos
7.
Biochem Biophys Res Commun ; 281(1): 94-100, 2001 Feb 16.
Artículo en Inglés | MEDLINE | ID: mdl-11178965

RESUMEN

We cloned two new paralogous genes that encode proteins homologous to seminal vesicle autoantigen (SVA) in rodents. The open reading frame of one mouse gene encodes a polypeptide consisting of 151 amino acid residues which has 43% identity to SVA. RT-PCR analysis showed selective expression in the colon, and thus the protein was tentatively named "SVA-like protein in the colon (SLP-C)". The other mouse gene has an open reading frame encoding 144 amino acid residues with 46 and 65% identity to SVA and SLP-C, respectively. Expression of this gene was detected in the mammary, submaxillary, parotid, and lacrimal glands, and this protein was named "SLP in the mammary gland (SLP-M)". Orthologs of both genes were also found in rats. The three homologous genes coding for SVA, SLP-C, and SLP-M may have been generated by gene duplication with divergence of tissue expression in the course of evolution. They comprise a unique structurally-related gene family. Moreover, these genes share significant sequence homology with that of another secretory glycoprotein, prolactin-inducible protein.


Asunto(s)
Autoantígenos/genética , Proteínas Portadoras/genética , Glicoproteínas/genética , Familia de Multigenes , Proteínas de Secreción de la Vesícula Seminal , Secuencia de Aminoácidos , Aminoácidos/química , Animales , Apoptosis , Ácido Aspártico Endopeptidasas , Autoantígenos/química , Secuencia de Bases , Clonación Molecular , Colon/metabolismo , ADN Complementario/metabolismo , Femenino , Glicoproteínas/química , Aparato Lagrimal/metabolismo , Hígado/metabolismo , Glándulas Mamarias Animales/metabolismo , Ratones , Sistemas de Lectura Abierta , Glándula Parótida/metabolismo , Péptidos/química , Filogenia , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Glándula Submandibular/metabolismo , Distribución Tisular
8.
Bioorg Med Chem Lett ; 10(19): 2213-6, 2000 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-11012032

RESUMEN

2'-Deoxyguanosine residues of a 3',5'-end-modified hexadeoxyribonucleotide (R-95288) with anti-HIV-1 activity were substituted with N2-methyl-2'-deoxyguanosine (m2dG). These modified oligodeoxyribonucleotides (ODNs) showed a 2-fold higher activity than R-95288. Also, the CD spectra of these ODNs indicated that the m2dG modification stabilized the tertiary structure of the G-quadruplex.


Asunto(s)
Fármacos Anti-VIH/síntesis química , Fármacos Anti-VIH/farmacología , Desoxiguanosina/química , VIH-1/efectos de los fármacos , Conformación de Ácido Nucleico , Oligodesoxirribonucleótidos/síntesis química , Oligodesoxirribonucleótidos/farmacología , Línea Celular , Dicroismo Circular , Evaluación Preclínica de Medicamentos , Humanos , Metilación , Estructura Molecular
9.
J Allergy Clin Immunol ; 105(6 Pt 1): 1202-10, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10856156

RESUMEN

BACKGROUND: Eosinophils are selectively recruited into the tissues during chronic allergic inflammation. IgE is considered an initiator of the allergic reaction; however, the roles of IgE in allergic inflammation are not fully understood. OBJECTIVE: We tested the hypothesis that antigen interaction with specific IgE antibody provokes eosinophilic inflammation. METHODS: BALB/c mice were actively sensitized with ragweed extract and passively sensitized with anti-dinitrophenyl (anti-DNP) mouse IgE and challenged intraperitoneally by injecting either ragweed extract or DNP-ovalbumin (OVA). Immediate anaphylactic responses were examined by monitoring vascular permeability and by measuring histamine content in peritoneal lavage fluids. Late-phase allergic responses were examined by total cell counts and cell differentials. RESULTS: Mice sensitized and challenged with ragweed showed immediate anaphylactic responses followed by temporal increases in neutrophils at 3 to 12 hours and sustained increases in eosinophils in their peritoneal cavities after 24 hours. Double-sensitized mice (ie, sensitized actively for ragweed and passively for DNP-OVA) challenged with ragweed showed immediate anaphylactic responses and peritoneal eosinophilia at 48 hours. Double-sensitized mice challenged with DNP-OVA showed comparable immediate anaphylactic responses but no peritoneal eosinophilia. Furthermore, at 8 hours, ragweed-challenged animals recruited both eosinophils and neutrophils, but DNP-OVA-challenged animals recruited only neutrophils. Finally, after active sensitization and challenge with ragweed, mast cell-deficient mice (WBB6F1-W/W(v)) lacked the immediate response but showed comparable eosinophil accumulation as their litter mate controls (WBB6F1-+/+). CONCLUSION: Interaction of antigen with IgE antibody is insufficient to provoke eosinophilic inflammation in mice.


Asunto(s)
Anafilaxia/etiología , Inflamación/etiología , Neutrófilos/patología , Receptores de IgE/fisiología , 2,4-Dinitrofenol/inmunología , Anafilaxia/patología , Animales , Antígenos , Modelos Animales de Enfermedad , Eosinófilos , Hipersensibilidad Inmediata/inmunología , Inmunización , Inmunización Pasiva , Masculino , Ratones , Ratones Endogámicos BALB C , Peritonitis/inmunología , Polen
10.
Surg Neurol ; 53(4): 323-9, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10825515

RESUMEN

BACKGROUND: Oxidation and/or free radical reactions after subarachnoid hemorrhage (SAH) may be involved in the development of chronic cerebral vasospasm. The inhibition of these reactions is thought to be one of the therapeutic strategies for prevention of cerebral vasospasm. We investigated the effect of Ebselen, a synthetic seleno-organic compound, which exhibits anti-oxidation by glutathione peroxidaselike activity to inhibit free radical reactions by lipid peroxidation on the development of chronic cerebral vasospasm in a primate model. METHODS: Seventeen monkeys were used. SAH was produced by introduction of a blood clot around the right middle cerebral artery and the right side of the circle of Willis in all animals. The monkeys were randomly divided into three groups according to Ebselen dosage: 1) no dosage or non-treated group; 2) high-dose Ebselen group; and 3) low-dose Ebselen group. The drug was administered at 10 mg/Kg in the high-dose group and 5 mg/Kg in the low-dose group twice a day in each group for 7 days after SAH. The vessel diameter was evaluated on angiograms before the induction of SAH and at Day 7 following SAH. RESULTS: In the untreated group, the angiograms showed significant (p < 0.05) reductions of the mean vessel caliber of the right internal carotid (ICA) (38 +/- 10% reduction) and the middle cerebral artery (MCA) (56 +/- 9.7%) compared with the baseline value before SAH. In the high-dose Ebselen-treated group, the mean percent reduction in vessel caliber of the right ICA (16 +/- 11%) and MCA (28 +/- 9.5%) on Day 7 angiograms were significantly (p < 0.05) lower than those in the nontreated group, whereas the mean percent reduction of these vessels in the low-dose Ebselen-treated group showed no significant difference compared with the untreated group. CONCLUSIONS: Chronic cerebral vasospasm was inhibited in the animals in which a relatively large amount of Ebselen was administered for 7 days after SAH. The results suggest that the oxidation or free radical reaction by lipid peroxidation after SAH might be involved in the pathogenesis of vasospasm, and that inhibition of these reactions by drugs, such as Ebselen, may have a promising effect for prevention of vasospasm.


Asunto(s)
Antioxidantes/uso terapéutico , Azoles/uso terapéutico , Compuestos de Organoselenio/uso terapéutico , Hemorragia Subaracnoidea/complicaciones , Vasoespasmo Intracraneal/tratamiento farmacológico , Vasoespasmo Intracraneal/etiología , Animales , Angiografía Cerebral/métodos , Enfermedad Crónica , Relación Dosis-Respuesta a Droga , Femenino , Isoindoles , Macaca fascicularis , Hemorragia Subaracnoidea/diagnóstico por imagen , Vasoespasmo Intracraneal/diagnóstico por imagen
11.
Immunopharmacology ; 44(3): 223-31, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10598879

RESUMEN

The effect of a Japanese ethical herbal drug, Hochu-ekki-to (HOT), on recovery from leukopenia induced by cyclophosphamide (CY) was investigated. Daily oral administration of 1000 mg/kg HOT into CY-treated mice significantly prevented decrease of leukocyte numbers in the peripheral blood and accelerated recovery from leukopenia. Ginsenoside Rgl extracted from Ginseng radix, a major herb of HOT, was one of the active ingredients. HOT increased numbers of neutrophils and monocytes in the peripheral blood compared with CY-treated control. Moreover, HOT augmented the resistance against Pseudomonas aeruginosa infection. The number of colony-forming units in the spleen (CFU-S) also increased in HOT-treated mice. The frequencies of IL-3-, GM-CSF- and IFN-gamma-producing cells increased in the spleen, bone marrow, liver and IEL on HOT treatment, and HOT clearly augmented the expressions of IL-3, GM-CSF and IFN-gamma mRNA in the spleen, bone marrow, liver and IEL except IL-3 and IFN-gamma mRNA in the IEL. These results suggest that HOT enhances the production of hematopoietic lymphokines, stimulates the proliferation of hematopoietic progenitor cells and consequently accelerates recovery from leukopenia in CY-treated mice. Additionally, IFN-gamma which HOT-augmented the production may contribute the protective effect against the bacterial infection by activating of phagocyte cells.


Asunto(s)
Ginsenósidos , Leucopenia/tratamiento farmacológico , Medicina Kampo , Fitoterapia , Saponinas/uso terapéutico , Animales , Células de la Médula Ósea/efectos de los fármacos , Ciclofosfamida , Citocinas/efectos de los fármacos , Femenino , Inmunosupresores , Recuento de Leucocitos/efectos de los fármacos , Leucopenia/sangre , Leucopenia/inducido químicamente , Linfocitos/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Ratones Endogámicos ICR , Monocitos/efectos de los fármacos , Neutrófilos/efectos de los fármacos , Extractos Vegetales/uso terapéutico
12.
Hepatogastroenterology ; 46(28): 2612-5, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10522050

RESUMEN

A 54 year-old man was admitted to our hospital and diagnosed with inoperable cancer in the body and tail of the pancreas. The spleen was embolized at its hilum with a coil to infuse an anti-tumor agent selectively into the pancreatic parenchyma and transcatheter intraarterial infusion (TAI) of styrene maleic acid neocarzinostatin (SMANCS)-Lipiodol, 3 mg, was performed. The computed tomography (CT) scan taken immediately after TAI revealed the incorporation of SMANCS-Lipiodol into the site of the pancreatic tail. At 2 weeks, a small amount of SMANCS-Lipiodol remained and clearness of the tumor margin was lacking in the pancreatic tail, but no remarkable change was noted in the body. As for the laboratory data, pancreatic enzyme level was not elevated immediately after TAI. At 2 weeks, tumor markers showed improvement in CEA (3.9-->2.6 ng/ml) and Elastase 1 (370-->230 ng/ml), but little change was seen in CA 19-9 (1600 U/ml: no change) and DUPAN-2 (730-->740 U/ml). In pancreatic cancer, SMANCS-Lipiodol could be infused from the splenic artery into the pancreatic parenchyma by the splenic arterial embolization.


Asunto(s)
Antineoplásicos/administración & dosificación , Infusiones Intraarteriales , Aceite Yodado/administración & dosificación , Anhídridos Maleicos/administración & dosificación , Neoplasias Pancreáticas/tratamiento farmacológico , Poliestirenos/administración & dosificación , Cinostatina/análogos & derivados , Biomarcadores de Tumor/análisis , Portadores de Fármacos , Embolización Terapéutica , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/diagnóstico por imagen , Arteria Esplénica , Tomografía Computarizada por Rayos X , Cinostatina/administración & dosificación
13.
Neurosci Lett ; 265(1): 64-6, 1999 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-10327207

RESUMEN

Nocistatin is a biologically active peptide derived from prepronociceptin, and its intrathecal administration has been reported to reduce nociceptin- or prostaglandin E2-induced hyperalgesia and allodynia in mice. In this study, we investigated the effects of intracerebroventricular (i.c.v.) administration of nocistatin on the inflammatory hyperalgesia induced by hindlimb intraplantar injection of carrageenan/kaolin in the rat paw-pressure test. Intracerebroventricular administration of nocistatin (0.5-50 pmol/rat) dose-dependently reduced carrageenan/kaolin-induced hyperalgesia, which peaked at 15-30 m. However, i.c.v. administration of nocistatin (50 pmol/rat) had no effect on the nociceptive threshold of non-inflamed rats. These results indicate that nocistatin has anti-hyperalgesic effects on the inflammatory hyperalgesia induced by carrageenan/kaolin at the supraspinal level.


Asunto(s)
Hiperalgesia/tratamiento farmacológico , Inflamación/inducido químicamente , Péptidos Opioides/uso terapéutico , Animales , Carragenina , Evaluación Preclínica de Medicamentos , Miembro Posterior , Hiperalgesia/etiología , Inyecciones Intraventriculares , Caolín , Masculino , Ratas , Ratas Sprague-Dawley
14.
Immunopharmacol Immunotoxicol ; 21(1): 125-40, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10084334

RESUMEN

Our previous study showed that the serum level of antigen-specific IgE antibodies in primary response was decreased by a traditional Chinese medicine, Bu-zhong-yi-qi-tang (Japanese name; Hochu-ekki-to, HOT). In this study, we examined inhibition of secondary IgE response and of eosinophil infiltration by HOT. BALB/c mice were intraperitoneally immunized with aluminum hydroxide adsorbed with DNP-KLH (DNP-KLH + alum) on day -14 and on day 0. In mice treated with HOT daily from day -14, the serum level of antigen-specific IgE antibodies after the secondary immunization was significantly decreased compared to that in mice not treated with HOT. Eosinophils increased in number after 6 and 24 hr, and CD4+ T cells in the peritoneal cavity increased in number 24 hr after the secondary immunization. HOT suppressed accumulation of eosinophils and CD4+ T cells in the peritoneal cavity. Furthermore, HOT suppressed the numbers of IL-4- and IL-5-producing cells 24 hr after the secondary immunization, but did not inhibit the number of IFN-gamma-producing cells. HOT also suppressed IL-5 mRNA expression. Furthermore, HOT also inhibited antigen-induced late-phase reaction (LPR) in the skin. These results suggested that HOT exhibited anti-allergic effects mainly by inhibiting Th2 cell responses.


Asunto(s)
Movimiento Celular/inmunología , Eosinófilos/inmunología , Medicina Tradicional China , Cavidad Peritoneal/patología , Adyuvantes Inmunológicos , Hidróxido de Aluminio/inmunología , Hidróxido de Aluminio/farmacología , Animales , Antígenos/inmunología , Linfocitos T CD4-Positivos/efectos de los fármacos , Inhibición de Migración Celular , Movimiento Celular/efectos de los fármacos , Citocinas/biosíntesis , Citocinas/metabolismo , Eosinófilos/efectos de los fármacos , Femenino , Inmunoglobulina E/biosíntesis , Inmunoglobulina E/inmunología , Interleucina-5/biosíntesis , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/inmunología , Extractos Vegetales/farmacología , Plantas Medicinales/química , ARN Mensajero/biosíntesis , Factores de Tiempo
15.
Int J Oncol ; 14(4): 673-9, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10087313

RESUMEN

The efficacy of granisetron hydrochloride 20 microg/kg and 40 microg/kg were compared using a cross-over method to determine the optimal dose in children with solid tumors receiving high-dose chemotherapy. Granisetron controlled the onset of vomiting in 17 of 23 patients (73.9%) who were given 40 microg/kg of granisetron, while 8 of 21 patients (38.1%) were free of vomiting in the 20 microg/kg group. The average frequency of vomiting was 7.22 times in the 20 microg/kg dose versus 4.44 times in the 40 microg/kg dose. No safety problems were associated with either dose. The 40 microg/kg dose of granisetron appears to be more optimal.


Asunto(s)
Antieméticos/uso terapéutico , Granisetrón/uso terapéutico , Vómitos/tratamiento farmacológico , Adolescente , Antieméticos/efectos adversos , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Niño , Preescolar , Estudios Cruzados , Ingestión de Alimentos/efectos de los fármacos , Femenino , Granisetrón/efectos adversos , Humanos , Lactante , Masculino , Neoplasias/tratamiento farmacológico , Factores de Tiempo , Resultado del Tratamiento , Vómitos/inducido químicamente
16.
J Nutr Sci Vitaminol (Tokyo) ; 45(5): 621-32, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10683813

RESUMEN

The characteristic cyclic variation in feed intake of rats fed a Zn-deficient diet (Mills et al, Am J Clin Nutr 22: 1240-1249 (1969)) followed a Cosinor curve, as determined by computer analysis (Tamaki et al, Br J Nutr 73: 711-722 (1995)). The values of amplitude for the feed-intake cycle had a positive correlation to their own day-to-day variations and to the correlation value of their own simulated cycles (r2 = 0.764, df = 50, p < 0.001 and r2 = 0.682, df = 50, p < 0.001, respectively). The cyclic variation in feed intake was accompanied by a cyclic variation in body-weight change in rats fed the Zn-deficient diet, and cyclic variation in body-weight change occurred similarly in pair-fed control rats. There were no differences in the mesors of body-weight change cycles of Zn-deficient rats and pair-fed control rats (Zn-deficient rats: 2.5 +/- 1.0 g/d, pair-fed rats: 2.8 +/- 1.0 g/d, mean +/- SD, df = 18, t = -0.674, ND). Rats fed the Zn-deficient diet were given different amounts of Zn supplementation by daily subcutaneous injection. The amplitude of the feed-intake cycle was decreased with increasing Zn supplementation (r2 = 0.919, df = 5, p < 0.001). The concentration of Zn for the appearance of the feed-intake cycle was estimated to be 71.6 +/- 6.6 micrograms/d per rat. The Zn level in the serum showed a significant decrease in the Zn-deficient diet groups, but the supplement of Zn did not vary in the Zn-deficient rats injected with up to 47.3 micrograms/d per rat. From these results, an analysis of the feed-intake cycle allowed us to estimate the quantitative Zn-deficient status of rats.


Asunto(s)
Dieta , Ingestión de Alimentos , Periodicidad , Zinc/administración & dosificación , Zinc/deficiencia , Animales , Peso Corporal , Masculino , Ratas , Ratas Wistar , Zinc/sangre
17.
J Nutr Sci Vitaminol (Tokyo) ; 43(3): 327-43, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9268921

RESUMEN

Rats fed a Zn-deficient diet develop a characteristic cyclic variation in feed intake (Mills et al., Am J Clin Nutr 22: 1240-1249 (1969). A preliminary analysis (Tamaki et al., Br J Nutr 73: 711-722 (1995)) of the cyclic variations was followed with a personal computer. Cosinor analysis revealed that the cyclic period of the feed intake of male rats was 3.5 +/- 0.05 d. The mesor, amplitude and acrophase value were 10.0 +/- 0.3 g/d, 4.4 +/- 0.2 g/d and 3.5 +/- 0.3 radian, respectively. The cycle of body-weight change of the Zn-deficient rats was well synchronized with that of feed intake. The parameters of the feed intake cycle had a high correlation to the corresponding parameters of body-weight change (mesor: r = 0.846; amplitude: r = 0.771; period: r = 0.925; acrophase: r = 0.452). With the supplementation of Zn (0.95-3.80 mg/kg of the Zn-deficient diet), cyclic variations in feed intake and body-weight change were also found. The mesor, amplitude and period of feed intake cycle were is good correlation with Zn intake (r = 0.856, p < 0.001, r = 0.804, p < 0.001 and r = 0.613, p < 0.01, respectively). The cycle of feed intake of the rats fed a Zn-free diet was simulated to be: mesor 9.7 +/- 0.1 g/d, amplitude 6.5 +/- 0.1 g/d and period 3.4 +/- 0.02 d. The concentration of Zn intake given the half-maximal value of the amplitude was assumed to be 56 +/- 1 microgram/d.


Asunto(s)
Dieta , Conducta Alimentaria , Zinc/deficiencia , Fosfatasa Alcalina/sangre , Animales , Peso Corporal , Femenino , Masculino , Ratas , Ratas Wistar , Zinc/administración & dosificación , Zinc/metabolismo
18.
Antiviral Res ; 34(3): 121-30, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9191019

RESUMEN

We analyzed the anti-HIV-1 activity of an oligonucleotide derivative, R-95288, in severe combined immunodeficient (SCID/beige) mice transplanted with normal human peripheral blood leukocytes (PBLs), designated hu-PBL-SCID/beige mice. The human chimeric mice were inoculated with HIV-1(CC1) 3 weeks after the transplantation and sacrificed 2 weeks later. Virus infection was determined by coculture of splenocytes with fresh human PBLs and also by detection of HIV- specific DNA sequences using the polymerase chain reaction. No evidence of infection was observed in mice treated with R-95288 (100 mg/kg/day) using intraperitoneal delivery by osmotic minipumps starting 1 day before virus challenge. In contrast, virus infection was observed in over 80% of the saline-treated control mice. In addition, partial inhibition of HIV-1 infection was obtained in mice treated subcutaneously with R-95288 (100 mg/kg/day). Toxicity towards the engrafted human cells was not observed by flow cytometric analysis. Moreover, R-95288 failed to inhibit lymphocyte proliferation (CC50 > 400 microg/ml), while 90% inhibition of HIV-1 replication was achieved at 3.1 microg/ml in vitro. These results suggest the ability of R-95288 to protect the human chimeric mice against HIV-1 infection.


Asunto(s)
Fármacos Anti-VIH/farmacología , Infecciones por VIH/prevención & control , VIH-1 , Oligonucleótidos/farmacología , Animales , Fármacos Anti-VIH/farmacocinética , Fármacos Anti-VIH/toxicidad , Quimera , ADN Viral/aislamiento & purificación , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Infecciones por VIH/virología , VIH-1/efectos de los fármacos , VIH-1/fisiología , Humanos , Transfusión de Leucocitos , Masculino , Ratones , Ratones SCID , Oligonucleótidos/farmacocinética , Oligonucleótidos/toxicidad , Bazo/virología , Trasplante Heterólogo , Replicación Viral/efectos de los fármacos
19.
Immunopharmacology ; 36(1): 79-85, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9129999

RESUMEN

The ability of a traditional herbal medicine, Bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to, HOT), to suppress IgE production was investigated. BALB/c mice were intraperitoneally immunized with aluminium hydroxide adsorbed with DNP-KLH (DNP-KLH + alum). When oral administration of HOT was begun just after immunization, the serum level of antigen-specific IgE was significantly decreased, although those of antigen-specific IgG1 and IgG2a were not influenced. In the culture of spleen cells obtained 14 days after immunization with DNP-KLH, antigen-specific IgE and IgG1 production by the cells of the HOT-treated mice was significantly suppressed compared to that in immunized mice. Furthermore, in the combination culture with CD4+ T cells and B cells separated from spleen cells, IgE production by the cells from immunized mice was inhibited by replacement of their corresponding cell population with either CD4+ T cells or B cells of HOT-treated mice. Additionally, production of interleukin 2 (IL-2) and IL-4 was significantly suppressed in HOT-treated mice but not that of IFN-gamma in comparison to the immunized mice. These results suggested that HOT decreased the IgE level in serum by inhibiting the development of IL-4-producing CD4+ T cells.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Inmunoglobulina E/biosíntesis , Compuestos de Alumbre/farmacología , Animales , Especificidad de Anticuerpos , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Linfocitos B/metabolismo , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Citocinas/biosíntesis , Epítopos , Femenino , Hemocianinas/inmunología , Hemocianinas/farmacología , Ratones , Ratones Endogámicos BALB C
20.
Res Commun Mol Pathol Pharmacol ; 95(2): 129-46, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9090750

RESUMEN

The effects of tetrandrine (TET), a Ca2+ antagonist of Chinese herbal origin, and hernandezine (HER), a structural analogue of TET, on Ca2+ mobilization were studied in rat glioma C6 cells. TET and HER alone did not affect the resting cytoplasmic Ca2+ concentration ([Ca2+]i). TET and HER inhibited the peak and sustained elevation of [Ca2+]i induced by bombesin and thapsigargin (TG), a microsomal Ca2+ ATPase inhibitor, in a dose-dependent manner. The doses of TET or HER needed to abolish the sustained and peak increase in [Ca2+]i induced by bombesin and TG were 30 microM and 300 microM, respectively. TET and HER did not increase inositol 1,4,5-trisphosphate (IP3) accumulation by themselves but inhibited IP3 accumulation elevated by bombesin. In permeabilized C6 cells, the addition of IP3 and TG released Ca2+ from intracellular stores. Pretreatment with TET or HER abolished Ca2+ release from intracellular stores induced by bombesin and TG. In the absence of extracellular Ca2+, the addition of 3 mM Ca2+ to extracellular medium slightly increased [Ca2+]i, which indicated Ca2+ entry due to leakage of Ca2+ at the plasma membrane but not Ca2+ influx through Ca2+ channels. TET and HER did not affect this leakage entry of Ca2+. The present results suggest that TET and HER inhibit Ca2+ release from intracellular stores as well as Ca2+ entry from extracellular medium evoked by bombesin and TG. In addition, TET and HER inhibit IP3 accumulation induced by bombesin in rat glioma C6 cells.


Asunto(s)
Alcaloides/farmacología , Antineoplásicos Fitogénicos/farmacología , Bencilisoquinolinas , Bloqueadores de los Canales de Calcio/farmacología , Calcio/metabolismo , Medicamentos Herbarios Chinos/farmacología , Glioma/metabolismo , Animales , Bombesina/toxicidad , División Celular/efectos de los fármacos , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/toxicidad , Glioma/patología , Inositol 1,4,5-Trifosfato/metabolismo , Ratas , Tapsigargina/toxicidad , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA